Efficacy of infliximab in refractory Behçet’s disease-associated and idiopathic posterior segment uveitis: a prospective, follow-up study of 50 patients
Fabrizio Cantini1, Laura Niccoli1, Carlotta Nannini1, Olga Kaloudi1, Emanuele Cassarà1, Massimo Susini2, Ivo Lenzetti21Second Division of Internal Medicine, Rheumatology Unit, 2Division of Ophthalmology, Prato Hospital, Prato, ItalyPurpose: To evaluate the long-term efficacy of inflix...
Enregistré dans:
Auteurs principaux: | Cantini F, Niccoli L, Nannini C, Kaloudi O, Cassarà E, Susini M, Lenzetti I |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2011
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/3a4aa02e84c34d2d856f787356bd17bb |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Current trends in the management of ocular symptoms in Adamantiades-Behçet’s disease
par: Fouad R Zakka, et autres
Publié: (2009) -
Neuro-Behçet’s disease: A report of sixteen patients
par: Radi Shahien, et autres
Publié: (2010) -
Long-term efficacy and safety of infliximab and cyclosporine combination therapy for refractory uveoretinitis in Behçet’s disease
par: Katsuyama A, et autres
Publié: (2019) -
Pattern of Uveitis Associated with Behçet’s Disease in an Egyptian Cohort
par: Abd El Latif E, et autres
Publié: (2020) -
Sustained maintenance of clinical remission after adalimumab dose reduction in patients with early psoriatic arthritis: a long-term follow-up study
par: Cantini F, et autres
Publié: (2012)